Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    14715398 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dysport® In Migraine Without Aura Prophylaxis : DIMWAP Study
Condition: Migraine Without Aura Prophylaxis
Intervention: Drug: Botulinum Toxin type A (Dysport ® ) IM/SC 6-sites pericranial injection
2 Recruiting Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment
Condition: Interstitial Cystitis
Interventions: Drug: Botulinum toxin A;   Drug: Normal saline instillation

Indicates status has not been verified in more than two years